{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:19:25Z","timestamp":1782487165131,"version":"3.54.5"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Health Expectations"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gout management remains suboptimal despite safe and effective urate\u2010lowering therapy. Self\u2010monitoring of urate may improve gout management, however, the acceptability of urate self\u2010monitoring by people with gout is unknown. The aim of this study was to explore the experiences of urate self\u2010monitoring in people with gout.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Semistructured interviews were conducted with people taking urate\u2010lowering therapy (<jats:italic>N<\/jats:italic>\u2009=\u200930) in a 12\u2010month trial of urate self\u2010monitoring in rural and urban Australia. Interviews covered the experience of monitoring and its effect on gout self\u2010management. Deidentified transcripts were analysed thematically.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants valued the ability to self\u2010monitor and gain more understanding of urate control compared with the annual monitoring ordered by their doctors. Participants indicated that self\u2010monitoring at home was easy, convenient\u00a0and informed gout self\u2010management behaviours such as dietary modifications, hydration, exercise\u00a0and medication routines. Many participants self\u2010monitored to understand urate concentration changes in response to feeling a gout flare was imminent or whether their behaviours, for example, alcohol intake, increased the risk of a gout flare. Urate concentrations were shared with doctors mainly when they were above target to seek management support, and this led to allopurinol dose increases in some cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Urate self\u2010monitoring was viewed by people with gout as convenient and useful for independent management of gout. They believed self\u2010monitoring achieved better gout control with a less restricted lifestyle. Urate data was shared with doctors at the patient's discretion and helped inform clinical decisions, such as allopurinol dose changes. Further research on implementing urate self\u2010monitoring in routine care would enable an evaluation of its impact on medication adherence and clinical outcomes, as well as inform gout management guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient or Public Contribution<\/jats:title><jats:p>One person with gout, who was not a participant, was involved in the study design by providing feedback and pilot testing the semistructured interview guide. In response to their feedback, subsequent modifications to the interview guide were made to improve the understandability of the questions from a patient perspective. No additional questions were suggested.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hex.14071","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T08:40:56Z","timestamp":1715676056000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The experiences and perspectives of people with gout on urate self\u2010monitoring"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6422-8683","authenticated-orcid":false,"given":"Toni J. F.","family":"Michael","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-7926","authenticated-orcid":false,"given":"Jian S.","family":"Chan","sequence":"additional","affiliation":[{"name":"St\u00a0Vincent's Clinical School Campus, Faculty of Medicine The University of New South Wales Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-5203","authenticated-orcid":false,"given":"Stephen","family":"Hughes","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-9252","authenticated-orcid":false,"given":"Daniel F. B.","family":"Wright","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia"},{"name":"St\u00a0Vincent's Clinical School Campus, Faculty of Medicine The University of New South Wales Sydney New South Wales Australia"},{"name":"Department of Clinical Pharmacology and Toxicology St Vincent's Hospital Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-1893","authenticated-orcid":false,"given":"Matthew J.","family":"Coleshill","sequence":"additional","affiliation":[{"name":"Black Dog Institute, Faculty of Medicine The University of New South Wales Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-7459","authenticated-orcid":false,"given":"Dyfrig A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation, North Wales Medical School Bangor University Wales UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6045-6937","authenticated-orcid":false,"given":"Richard O.","family":"Day","sequence":"additional","affiliation":[{"name":"St\u00a0Vincent's Clinical School Campus, Faculty of Medicine The University of New South Wales Sydney New South Wales Australia"},{"name":"Department of Clinical Pharmacology and Toxicology St Vincent's Hospital Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-8236","authenticated-orcid":false,"given":"Parisa","family":"Aslani","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-587X","authenticated-orcid":false,"given":"Sophie L.","family":"Stocker","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia"},{"name":"Department of Clinical Pharmacology and Toxicology St Vincent's Hospital Sydney New South Wales Australia"},{"name":"Sydney Infectious Diseases Institute, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia"},{"name":"Sydney Musculoskeletal Health, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,5,14]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00346-9"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41404"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.071229"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00319-2"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02772-3"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15435"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15657"},{"key":"e_1_2_11_9_1","unstructured":"Gout.Australian Medicines Handbook Pty Ltd. Accessed May 7 2024.\u00a0https:\/\/amhonline.amh.net.au\/chapters\/rheumatological-drugs\/drugs-gout\/gout"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11121"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1056-7"},{"issue":"4","key":"e_1_2_11_12_1","first-page":"241","article-title":"Patients and tests: a study into patient understanding of blood tests ordered by their doctor","volume":"41","author":"Kljakovic M","year":"2012","journal-title":"Aust Fam Physician"},{"key":"e_1_2_11_13_1","unstructured":"Australian Government Department of Health.\u00a0Australian National Diabetes Strategy 2021\u20132030. Australian Government Department of Health;\u00a02021. Accessed May 7 2024.https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2021\/11\/australian-national-diabetes-strategy-2021-2030_0.pdf"},{"key":"e_1_2_11_14_1","unstructured":"National Heart Foundation of Australia.\u00a0Guidelines for the Diagnosis and Management of Hypertension in Adults\u20142016. NHF; 2016. Accessed May 7 2024.https:\/\/www.heartfoundation.org.au\/for-professionals\/hypertension"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11666"},{"key":"e_1_2_11_16_1","unstructured":"Australian Bureau of Statistics.Australian Statistical Geography Standard (ASGS) Edition 3.\u00a0Australian Bureau of Statistics;\u00a02023. Accessed May 7 2024.https:\/\/www.abs.gov.au\/statistics\/standards\/australian-statistical-geography-standard-asgs-edition-3\/jul2021-jun2026"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1742395310378761"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4524"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2838-1"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2012.0135"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39302.444572.DE"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/edn.122"},{"key":"e_1_2_11_24_1","first-page":"237","article-title":"Barriers and facilitators to self\u2010monitoring of blood glucose in people with type 2 diabetes using insulin: a qualitative study","volume":"8","author":"Ong WM","year":"2014","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kay028"},{"issue":"500","key":"e_1_2_11_26_1","first-page":"183","article-title":"Blood glucose self\u2010monitoring in non\u2010insulin\u2010treated type 2 diabetes: a qualitative study of patients' perspectives","volume":"54","author":"Peel E","year":"2004","journal-title":"Br\u00a0J Gen Pract"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0394-6"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2006.07.007"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.112925"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002671"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00242-0"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22785"},{"issue":"10","key":"e_1_2_11_34_1","first-page":"19374","article-title":"Intensified glucose self\u2010monitoring with education in Saudi DM patients","volume":"8","author":"Ba\u2010Essa EM","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03268.x"},{"issue":"4","key":"e_1_2_11_36_1","first-page":"287","article-title":"Intensified treatment of type 1 diabetes: prospective evaluation at one year of a therapeutic patient education programme","volume":"28","author":"Lemozy\u2010Cadroy S","year":"2002","journal-title":"Diabetes Metab"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-7-2"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.5977\/jkasne.2013.19.2.127"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/08870446.2018.1432760"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0105-RA"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S247774"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00062-5"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1666"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.7.1244-a"},{"key":"e_1_2_11_45_1","first-page":"1","article-title":"Factors determining patients' intentions to use point\u2010of\u2010care testing medical devices for self\u2010monitoring: the case of international normalized ratio self\u2010testing","volume":"7","author":"Shah SG","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvdhj.2021.02.001"},{"key":"e_1_2_11_47_1","unstructured":"National Diabetes Services Scheme. Products. Accessed May 7 \u00a02024.https:\/\/www.ndss.com.au\/products\/"},{"key":"e_1_2_11_48_1","unstructured":"Australian Government Department of Health. Medicare benefits schedule\u2014item 73812. Accessed May 7 2024.https:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/Home"},{"key":"e_1_2_11_49_1","unstructured":"Australian Government Department of Health. Medicare benefits schedule\u2014item 11607. Accessed May 7 2024.https:\/\/www.mbsonline.gov.au\/internet\/mbsonline\/publishing.nsf\/Content\/Home"}],"container-title":["Health Expectations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hex.14071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:34:14Z","timestamp":1758890054000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hex.14071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1111\/hex.14071"],"URL":"https:\/\/doi.org\/10.1111\/hex.14071","archive":["Portico"],"relation":{},"ISSN":["1369-6513","1369-7625"],"issn-type":[{"value":"1369-6513","type":"print"},{"value":"1369-7625","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]},"assertion":[{"value":"2024-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14071"}}